Incidental discovery of acute myeloid leukemia during liquid biopsy of a lung cancer patient.

Abstract excerpt

Liquid biopsy is considered an alternative to standard next-generation sequencing (NGS) of solid tumor samples when biopsy tissue is inadequate for testing or when testing of a peripheral blood sample is preferred. A common assumption of liquid biopsies is that the NGS data obtained on circulating cell-free DNA is a high-fidelity reflection of what would be found by solid tumor testing. Here, we describe a case...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biopsy, Fine-Needle
• Share to DNA Mutational Analysis